Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation

DSpace Repository

Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation

Author: Ho, Jenny N. H. G.; Schmidt, Dominik; Lowinus, Theresa; Ryoo, Jeongmin; Dopfer, Elaine-Pashupati; Nunez, Nicolas Gonzalo; Costa-Pereira, Sara; Toffalori, Cristina; Punta, Marco; Fetsch, Viktor; Wertheimer, Tobias; Rittmann, Marie-Claire; Braun, Lukas M.; Follo, Marie; Briere, Christelle; Vinnakota, Janaki Manoja; Langenbach, Marlene; Koppers, Felicitas; Shoumariyeh, Khalid; Engel, Helena; Ruckert, Tamina; Marklin, Melanie; Holzmayer, Samuel; Illert, Anna L.; Magon, Federica; Andrieux, Geoffroy; Duquesne, Sandra; Pfeifer, Dietmar; Staniek, Julian; Rizzi, Marta; Miething, Cornelius; Kohler, Natalie; Duyster, Justus; Menssen, Hans D.; Boerries, Melanie; Buescher, Joerg M.; Cabezas-Wallscheid, Nina; Blazar, Bruce R.; Apostolova, Petya; Vago, Luca; Pearce, Erika L.; Becher, Burkhard; Zeiser, Robert
Tübinger Autor(en):
Marklin, Melanie
Holzmayer, Samuel
Published in: Blood (2022), Bd. 140, H. 10, S. 1167-1181
Verlagsangabe: Amer Soc Hematology
Language: English
Full text: http://dx.doi.org/10.1182/blood.2022016082
ISSN: 0006-4971
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)